Ekaterina Laukhtina
Medical University of Vienna
Internal medicineUrologySurgeryOncologyFiber laserEnucleationHazard ratioCystectomyProstateProstatectomyProstate cancerBladder cancerIn patientProportional hazards modelLaserMedicineBiomarker (medicine)Meta-analysis
95Publications
8H-index
133Citations
Publications 119
Newest
#1Reza Sari Motlagh (Shahid Beheshti University of Medical Sciences and Health Services)H-Index: 6
#2Pawel Rajwa (Medical University of Silesia)H-Index: 5
Last. Shahrokh F. ShariatH-Index: 136
view all 15 authors...
Introduction: It has been hypothesized that transurethral en bloc (TUEB) of bladder tumor offers benefits over conventional transurethral resection of bladder tumor (cTURBT). This study aimed to co...
Source
#1Takafumi Yanagisawa (Medical University of Vienna)
#2Keiichiro Mori (Medical University of Vienna)H-Index: 10
Last. Shahrokh F. ShariatH-Index: 136
view all 16 authors...
Pembrolizumab is the standard for the first and second lines in treating metastatic urothelial carcinoma (UC). This systematic review and meta-analysis aimed to assess the value of pretreatment clinical characteristics and hematologic biomarkers for prognosticating response to pembrolizumab in patients with metastatic UC. PUBMED®, Web of Science™, and Scopus® databases were searched for articles published before May 2021 according to the PRISMA (Preferred Reporting Items for Systematic Review an...
Source
#1M Carmen Mir (Yahoo!)H-Index: 5
#2Tamsin Greenwell (UCL: University College London)H-Index: 25
view all 9 authors...
Source
#1Ekaterina Laukhtina (Medical University of Vienna)H-Index: 8
#2Sung Ryul Shim (KU: Korea University)H-Index: 1
Last. Benjamin Pradere (Medical University of Vienna)H-Index: 16
view all 22 authors...
Abstract null null Context null During the past decade, several urinary biomarker tests (UBTs) for bladder cancer have been developed and made commercially available. However, none of these is recommended by international guidelines so far. null null null Objective null To assess the diagnostic estimates of novel commercially available UBTs for diagnosis and surveillance of non–muscle-invasive bladder cancer (NMIBC) using diagnostic test accuracy (DTA) and network meta-analysis (NMA). null null ...
Source
The gene coding for histone methyltransferase KMT2D is found among the top mutated genes in upper tract urothelial carcinoma (UTUC); however, there is a lack of data regarding its association with clinicopathologic features as well as survival outcomes. Therefore, we aimed to investigate KMT2D expression, mutation patterns, and their utility as prognostic biomarkers in patients with UTUC. A single-center study was conducted on tumor specimens from 51 patients treated with radical nephroureterect...
Source
#1Stefano Luzzago (IEO: European Institute of Oncology)H-Index: 12
#2M.L. Piccinelli (University of Milan)H-Index: 1
Last. Gennaro Musi (IEO: European Institute of Oncology)H-Index: 5
view all 17 authors...
To test discontinuation rates during Active Surveillance (AS) in patients diagnosed with incidental prostate cancers (IPCa) vs. tumors diagnosed at prostate biopsies (BxPCa). Retrospective single center analysis of 961 vs. 121 BxPCa vs. IPCa patients (2008–2020). Kaplan–Meier plots and multivariable Cox regression models tested four different outcomes: (1) any-cause discontinuation; (2) discontinuation due to ISUP GG upgrading; (3) biopsy discontinuation due to ISUP GG upgrading or > 3 positive ...
Source
#1Ekaterina Laukhtina (Medical University of Vienna)H-Index: 8
#2Victor M. Schuettfort (UHH: University of Hamburg)H-Index: 5
Last. Shahrokh F. ShariatH-Index: 136
view all 16 authors...
Introduction null This study aimed to determine the prognostic value of a panel of SIR-biomarkers, relative to standard clinicopathological variables, to improve mRCC patient selection for cytoreductive nephrectomy (CN). null Material and methods null A panel of preoperative SIR-biomarkers, including the albumin-globulin ratio (AGR), De Ritis ratio (DRR), and systemic immune-inflammation index (SII), was assessed in 613 patients treated with CN for mRCC. Patients were randomly divided into train...
Source
#1Keiichiro Mori (Jikei University School of Medicine)H-Index: 10
#2Satoshi Katayama (Medical University of Vienna)H-Index: 3
Last. Shahrokh F. Shariat (UTSW: University of Texas Southwestern Medical Center)H-Index: 136
view all 19 authors...
Introduction null This study aimed to evaluate the concordance in tumor stage and grade between ureteroscopic (URS) biopsy and radical nephroureterectomy (RNU) in patients with upper tract urothelial carcinoma (UTUC). null Patients and methods null Records of 1,214 UTUC patients who had undergone URS biopsy followed by RNU were included. Univariable and multivariable logistic regression analyses were performed to identify factors contributing to the pathological upstaging. null Results null The ...
Source
#1Ekaterina Laukhtina (Medical University of Vienna)H-Index: 8
#2Victor M. Schuettfort (UHH: University of Hamburg)H-Index: 5
Last. Shahrokh F. ShariatH-Index: 136
view all 23 authors...
Elevated preoperative plasma level of endoglin has been associated with worse oncologic outcomes in various malignancies. The present large-scale study aimed to determine the predictive and prognostic values of preoperative endoglin with regard to clinicopathologic and survival outcomes in patients treated with radical cystectomy (RC) for nonmetastatic urothelial carcinoma of the bladder (UCB). We prospectively collected preoperative blood samples from 1036 consecutive patients treated with RC f...
Source
#1Satoshi KatayamaH-Index: 3
Last. Abdulmajeed AydhH-Index: 5
view all 23 authors...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.